SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-211446
Filing Date
2023-08-14
Accepted
2023-08-14 07:15:28
Documents
14
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d513429d8k.htm   iXBRL 8-K 26504
2 EX-99.1 d513429dex991.htm EX-99.1 10541
6 GRAPHIC g513429g0812045640466.jpg GRAPHIC 4402
  Complete submission text file 0001193125-23-211446.txt   169264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230814.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230814_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230814_pre.xml EX-101.PRE 11275
8 EXTRACTED XBRL INSTANCE DOCUMENT d513429d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 231166211
SIC: 2834 Pharmaceutical Preparations